The minds behind the Pfizer BioNTech COVID-19 vaccine have revealed that a cancer jab could be ready before this decade ends in 2030.
The Independent reported that co-founders of BioNTech, who partnered up with Pfizer for the COVID jab, are hopeful that their breakthroughs for melanomas, bowel cancer and other tumour cancers could translate into an operable vaccine.
Uğur Şahin and Özlem Türeci expressed some hesitation about announcing the medical technology, but the latter said that their work on the COVID-19 vaccine led them to finding a potential cure.
‘We have learned how to better, faster manufacture vaccines. We have learned in a large number of people how the immune system reacts towards mRNA’ said Türeci.
In a nutshell, the COVID jab’s mRNA technology could be repurposed to enhance the bodily immune system while attacking cancerous cells. The mRNA recreates antigens and tells the body what to search for and what to target.
Türeci described the mRNA as a wanted poster for the cancerous cells and thus won’t target other healthy cells. The predicted finish line is 2030 and the COVID jab rollout could even indicate how effective use could become.